Document is current

Article History

Received: 15 June 2024

Accepted: 17 January 2025

First Online: 24 March 2025

Declarations

:

: This study was approved by the Ethics Committee of Bellvitge University Hospital (PR043/22).

: Due to the retrospective nature of the study, conducted more than five years after the last patient was studied, and its exploratory design, the institution’s ethics committee determined that obtaining individual consent from each participant was not mandatory. This decision was based on the fact that no individual patient data are disclosed, nor can any participant be identified.

: Not applicable.

: This work was presented in part at the XXXVII Diada Pneumològica April 4–6, 2019; 5th European Congress for Bronchology and Interventional Pulmonology (ECBIP), May 8–11, 2019; XXV Congreso AAER, May 24–25, 2019; 52º Congreso SEPAR, June 13–16, 2019; World Conference on Lung Cancer, September 7–10, 2019; ERS International Congress, September 28 – October 02, 2019 and Radiological Society of North America (RSNA) 105th Scientific Assembly and Annual Meeting December 1–6, 2019.

: The authors have no commercial or financial interests to disclose related to this study.

: The authors declare no competing interests.